Company Overview
WEST PHARMACEUTICAL SERVICES INC
WSTRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
3,074M
2025 FY
Net Income
494M
2025 FY
Shares Outstanding
72M
2025 FY
EPS
6.83USD
2025 FY
Company Information
SIC Code
3841
CIK Code
105770
Exchange
NYSE
Location
US